Stay updated on Nivolumab for IDH Mutant Gliomas Clinical Trial

Sign up to get notified when there's something new on the Nivolumab for IDH Mutant Gliomas Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab for IDH Mutant Gliomas Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    Revision label updated from v3.5.4 to v3.5.5 on the page, indicating a minor platform update.
    Difference
    0.1%
    Check dated 2026-06-05T08:28:55.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    A new revision tag v3.5.4 was added, replacing the previous v3.5.3. This indicates the page has been updated to a newer revision.
    Difference
    0.1%
    Check dated 2026-05-15T02:18:16.000Z thumbnail image
  5. Check
    36 days ago
    Change Detected
    Summary
    Revision: v3.5.3 replaces v3.5.2 on the page, signaling a version update. This update is a technical patch and does not change the study data or presented content.
    Difference
    0.1%
    Check dated 2026-04-30T15:24:08.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    Revision indicator updated to v3.5.2; previous revision v3.5.0 was removed.
    Difference
    0.1%
    Check dated 2026-04-16T09:40:07.000Z thumbnail image
  7. Check
    72 days ago
    Change Detected
    Summary
    Added revision: v3.5.0. Deleted revision: v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-25T20:33:56.000Z thumbnail image
  8. Check
    86 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.2 to v3.4.3 in the header. No changes to study content or page layout were observed.
    Difference
    0.1%
    Check dated 2026-03-11T15:33:33.000Z thumbnail image

Stay in the know with updates to Nivolumab for IDH Mutant Gliomas Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab for IDH Mutant Gliomas Clinical Trial page.